Skip to main content

Advertisement

Log in

Theoretical and Experimental Analysis of Anti-A Antibody Capture in Novel Integrated Bead and Hollow Fiber Modules

  • Published:
Annals of Biomedical Engineering Aims and scope Submit manuscript

Abstract

Anti-A/B antibody removal from blood reduces the hyperacute rejection risk following ABO-incompatible transplantation. We are developing an integrated bead and fiber module (BSAF) that selectively removes anti-A from blood. In BSAF blood flows through the inner lumen of microfiltration fibers. Starling flow carries plasma from the inner fiber lumen to the beads in the shell compartment where antibodies bind to covalently attached antigens on the beads. In this study, we developed a mathematical model to guide the choice of key design and operational parameters for a clinical BSAF device. The model demonstrated that for a given flow rate and reservoir volume, antibody removal rate was dependent on the magnitude of a lumped parameter, k L m B/Q s, that characterizes the ratio of antibody uptake rate by the beads to the Starling flow rate in the device. The highest antibody removal rate was predicted for the perfusion limited regime, when k L m B/Q s → 10; Once this maximum limit was obtained, any further increase in the antibody removal rate was only possible by increasing the flow rate. Key model predictions were validated in a series of experiments. The model was then used to conceptually design a BSAF capable of a clinically relevant rate of anti-A removal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Alexandre, G. P., et al. Human ABO-incompatible living donor renal homografts. Neth. J. Med. 28:231–234, 1985.

    CAS  PubMed  Google Scholar 

  2. Alikhani, A., et al. High molecular weight blood group A trisaccharide-polyacrylamide glycoconjugates as synthetic blood group A antigens for anti-A antibody removal devices. J. Biomed. Mater. Res. B 91:845–854, 2009.

    Google Scholar 

  3. Apelblat, A., et al. A mathematical analysis of capillary–tissue fluid exchange. Biorheology 11:1–49, 1974.

    CAS  PubMed  Google Scholar 

  4. Bannett, A. D., et al. Experiences with known ABO-mismatched renal transplants. Transplant. Proc. 19:4543–4546, 1987.

    CAS  PubMed  Google Scholar 

  5. Bird, R. B., et al. Transport Phenomena. New York: Wiley, 2002.

    Google Scholar 

  6. Boberg, K. M., et al. ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody. Clin. Transplant. 20:265–268, 2006.

    Article  CAS  PubMed  Google Scholar 

  7. Bovin, N. Polyacrylamide-based glycoconjugates as tools in glycobiology. Glycoconj. J. 15:431–446, 1998.

    Article  CAS  PubMed  Google Scholar 

  8. Bovin, N. V., et al. Synthesis of polymeric neoglycoconjugates based on n-substituted polyacrylamides. Glycoconj. J. 10:142–151, 1993.

    Article  CAS  PubMed  Google Scholar 

  9. Donauer, J., et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience. Xenotransplantation 13:108–110, 2006.

    Article  PubMed  Google Scholar 

  10. Ettenauer, M., et al. Magnetic fluorescent microparticles as markers for particle transfer in extracorporeal blood purification. Biomacromolecules 12:3693–3696, 2007.

    Article  Google Scholar 

  11. Fukunaga, K., et al. Preliminary evaluation study of a prototype hollow fiber membrane for the continuous membrane autotransfusion system. Ther. Apher. 3:63–68, 1999.

    Article  CAS  PubMed  Google Scholar 

  12. Furst, D., et al. Immunoadsorption for the treatment of rheumatoid arthritis: final results of a randomized trial. Ther. Apher. 4:363–373, 2000.

    Article  CAS  PubMed  Google Scholar 

  13. Gautam, S., et al. Monoclonal anti-A antibody removal by synthetic A antigen immobilized on specific antibody filters. Biotechnol. Bioeng. 99:876–883, 2008.

    Article  CAS  PubMed  Google Scholar 

  14. Goldsby, R. A., et al. Immunology. New York: W.H. Freeman and Company, 2003.

    Google Scholar 

  15. Hanto, D. W., et al. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl. 9:22–30, 2003.

    Article  PubMed  Google Scholar 

  16. Heidrun, U., et al. Improved treatment of sudden hearing loss by specific fibrinogen aphaeresis. J. Clin. Apher. 19:71–78, 2004.

    Article  Google Scholar 

  17. Hermanson, G. T., et al. Immobilized Affinity Ligand Techniques. San Diego: Academic Press Inc., 1992.

    Google Scholar 

  18. Hout, M. S., and W. J. Federspiel. Mathematical and experimental analyses of antibody transport in hollow-fiber-based specific antibody filters. Biotechnol. Prog. 19:1553–1561, 2003.

    Article  CAS  PubMed  Google Scholar 

  19. Hout, M. S., et al. Specific removal of anti-A and anti-B antibodies by using modified dialysis filters. ASAIO J. 46:702–706, 2000.

    Article  CAS  PubMed  Google Scholar 

  20. Korchagina, E. Y., and N. V. Bovin. Synthesis of spacered trisaccharides with blood group A and B specificities and fragments and structural analogues of them. Sov. J. Bioorg. Chem. 18:153–165, 1992.

    Google Scholar 

  21. Mor, E., et al. Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients. Transplantation 59:986–990, 1995.

    Article  CAS  PubMed  Google Scholar 

  22. Norden, G., et al. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Xenotransplantation 13:148–153, 2006.

    Article  PubMed  Google Scholar 

  23. Rieben, R., et al. In vitro evaluation of the efficacy and biocompatibility of new, synthetic ABO immunoabsorbents. Transplantation 60:425–430, 1995.

    Article  CAS  PubMed  Google Scholar 

  24. Rydberg, L. ABO-incompatibility in solid organ transplantation. Transfus. Med. 11:325–342, 2001.

    Article  CAS  PubMed  Google Scholar 

  25. Rydberg, L., et al. In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose. Transpl. Int. 17:666–672, 2005.

    Article  CAS  PubMed  Google Scholar 

  26. Skogsberg, U., et al. Adult ABO-incompatible liver transplantation, using A and B donors. Xenotransplantation 13:154–159, 2006.

    Article  PubMed  Google Scholar 

  27. Solovan, J. C., et al. Synthetic blood group antigens for anti-A removal device and their interaction with monoclonal anti-A IgM. Transpl. Immunol. 16:245–249, 2006.

    Article  CAS  PubMed  Google Scholar 

  28. Starling, E. H. On the absorption of fluid from the connective tissue space. J. Physiol. 19:312–326, 1896.

    CAS  PubMed  Google Scholar 

  29. Tanabe, K., et al. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation 65:224–228, 1998.

    Article  CAS  PubMed  Google Scholar 

  30. Thomas, B., et al. State of the art of low-density lipoprotein apheresis in the year 2003. Ther. Apher. Dial. 8:76–79, 2004.

    Article  Google Scholar 

  31. Troisi, R., et al. ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppression without splenectomy. Liver Transpl. 12:1412–1417, 2006.

    Article  PubMed  Google Scholar 

  32. Tydén, G., et al. The European experience. Transplantation 84(12 Suppl):S2–S3, 2007.

    Article  PubMed  Google Scholar 

  33. Unger, J. K., et al. Maximal flow rates and sieving coefficients in different plasmafilters: effects of increased membrane surfaces and effective length under standardized in vitro conditions. J. Clin. Apher. 17:190–198, 2002.

    Article  CAS  PubMed  Google Scholar 

  34. Watkins, W. M. The ABO blood group system: historical background. Transfus. Med. 11:243–265, 2001.

    Article  CAS  PubMed  Google Scholar 

  35. Weber, C., and D. Falkenhagen. Extracorporeal removal of proinflammatory cytokines by specific absorption onto microspheres. ASAIO J. 42:M908–M911, 1996.

    Article  CAS  PubMed  Google Scholar 

  36. Weber, V., et al. Efficient adsorption of tumor necrosis factor with an in vitro set-up of the microspheres-based detoxification system. Blood Purif. 25:169–174, 2007.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The work presented in this publication was made possible by Grant Number HL69956-01 from the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Heart, Lung, and Blood Institute or NIH. We would like to recognize the McGowan Institute for Regenerative Medicine for support on this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William J. Federspiel.

Additional information

Associate Editor Bahman Anvari oversaw the review of this article.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alikhani, A., Federspiel, W.J. Theoretical and Experimental Analysis of Anti-A Antibody Capture in Novel Integrated Bead and Hollow Fiber Modules. Ann Biomed Eng 39, 953–963 (2011). https://doi.org/10.1007/s10439-010-0233-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10439-010-0233-x

Keywords

Navigation